Top 4 Small-Cap Stocks In The Drug Stores Industry With The Highest Revenue Estimates

Below are the top small-cap drug stores stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.

Analysts expect Rite Aid (NYSE: RAD) to post revenue of $25.36 billion for the year ending February, 2013. Rite Aid had $263.64 million in total cash for the latest quarter.

PharMerica (NYSE: PMC) is likely to post revenue of $1.83 billion in the year ending December, 2012. PharMerica's trailing-twelve-month operating margin is 3.88%.

BioScrip (NASDAQ: BIOS) may report revenue of $651.40 million in the current year ending December, 2012. BioScrip's trailing-twelve-month ROE is 1.61%.

China Nepstar Chain Drugstore (NYSE: NPD) is expected to report revenue of $395.83 million for the current year. China Nepstar's trailing-twelve-month ROA is 1.70%.